News

PharmiWeb33m
Astoriom appoints Ryan Smith as Global Head of Sales
Key appointment to support company in scaling biorepository and stability storage operationsRochdale, UK, 28 April 2025: ...
PharmiWeb15m
PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference
Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...
PharmiWeb48m
May is Teen Mental Health Awareness Month Avel eCare Provides Crucial Support for Teens in Crisis-At Home and In School
SIOUX FALLS, SD / ACCESS Newswire / May 1, 2025 / Teen mental health has reached a crisis point in the United States. According to the CDC, nearly 1 in 3 high school girls reported seriously ...
PharmiWeb48m
enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24
Cash Burn of $4.0 million in Q1 remains in line with projected quarterly rangeCash and investments on hand are sufficient to fund operations beyond the anticipated FDA decision of VenoValve and the ...
PharmiWeb48m
Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences
BRIDGEWATER, NJ / ACCESS Newswire / May 1, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative ...